KLIFO
Niels Peder Nielsen is a seasoned professional with extensive experience in advisory and board roles across various companies. Currently serving as a Senior Advisor at Bain & Company and Chairman of the Board of Directors at KLIFO, Niels Peder Nielsen also holds directorships with NOON Ventures, Enduro, and Mark Information, among others. Previously, Niels Peder Nielsen was a Deputy CEO at Novo Nordisk Foundation and a senior partner at Bain & Company, where leadership of the Danish office and expertise in Financial Services were key responsibilities. Niels Peder Nielsen's educational background includes a Bachelor of Business Administration in Finance from Copenhagen Business School and an advanced degree from the MIT Sloan School of Management.
This person is not in any teams
KLIFO
KLIFO is an integrated North-European drug development consultancy with significant experience in partnering with pharmaceutical and biotech companies. We enable our partners to maximise opportunity, mitigate risks, drive innovation and achieve efficient project advancement. We offer end to end solutions across all drug development areas, including strategic project management, regulatory affairs, clinical development, clinical trial supply, quality assurance (QA), Chemistry Manufacturing and Controls (CMC) development, non-clinical development and pharmacovigilance in relation to the development of pharmaceutical products. We provide strategic advice as well as operational support in all these areas, and we partner with clients on portfolio strategies, project development strategies and project execution. KLIFO has offices in Denmark, Sweden, Germany and The Netherlands and employs more than 150 highly skilled employees.